Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

ALK-Abello

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ALK-Abello's 2013 sales performance.

ALK-Abello debuts its birch pollen allergy therapy in Germany

ALK-Abello debuts its birch pollen allergy therapy in Germany

Key market for the new product. Danish drugmaker ALK-Abello has launched its tree pollen immunotherapy Itulazax in Germany, its first market, following its European approval earlier this year. ... Tree pollen allergy is highly prevalent in northern Europe

Positive mid-stage trial gives Allergy’s investors some welcome relief

Positive mid-stage trial gives Allergy’s investors some welcome relief There are already immunotherapies on the market for grass pollen allergy - including for example Alk Abello/Merck &Co’s oral Grazax/Grastek product - but these can take months of treatment to

ALK-Abello appoints Søren Jelert as CFO

ALK-Abello appoints Søren Jelert as CFO He will be based at the company’s headquarters in Denmark. Dansih allergy immunotherapy company ALK-Abello has appointed Søren Jelert as its new chief financial officer, a role that sees ... ALK.”. Jelert will be based at ALK’s headquarters in

Cello Health Consulting expands its UK team

Cello Health Consulting expands its UK team Tarplee has over 30 years of life science industry experience and previously worked for the likes of Adherium, ALK Abello, Sanofi and Abbott.

Deal Watch July 2016

Deal Watch July 2016 And Finally, Reality Bites. ALK-Abello has issued a press release announcing that Merck &Co has walked away from the deal agreed in 2007 (with Schering-Plough) for the allergy treatments ... No sales figures have been released by either side, but

1 2 3 4 5 6 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics